19th International Conference on Pharmaceutical Engineering and Pharmacovigilance
|19th International Conference on Pharmaceutical Engineering and Pharmacovigilance|
|Date||May 28 - 29, 2017|
"The ICPEP 2017: 19th International Conference on Pharmaceutical Engineering and Pharmacovigilance aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmaceutical Engineering and Pharmacovigilance. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmaceutical Engineering and Pharmacovigilance."
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Pharmaceutical Engineering and Pharmacovigilance are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.
All submitted conference papers will be blind peer reviewed by three competent reviewers. The post conference proceedings will be abstracted and indexed in the International Science Index, and submitted to be indexed in the Google Scholar, Scopus and Thomson Reuters. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk.
Special Journal Issues
ICPEP 2017 has teamed up with the Special Journal Issue on Pharmaceutical Engineering and Pharmacovigilance.
A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge....
|Abstracts/Full-Text Paper Submission Deadline||March 20, 2017|
|Notification of Acceptance/Rejection||March 31, 2017|
|Final Paper Submission & Early Bird Registration Deadline||April 28, 2017|
|Conference Dates||May 28 - 29, 2017|
Conference Registration Fees
Author Conference Registration includes "Paper Presentation, Proceedings Volume Part (where your paper is published), Proceedings CD, Attendance to all Sessions, Conference Programme, Name Tag, Luncheons and Coffee Breaks, Certificate of Attendance and Presentation, and Small Handbag".
Listener Conference Registration includes Attendance to All Sessions, Proceedings CD, Conference Programme, Name Tag, Luncheons and Coffee Breaks, Certificate of Attendance and Small Handbag.
Early Bird Registration
Early Bird registration was valid until 2017-04-28 23:59:59
|Participation Type||Early Registration Fees||Registration Fees|
|Non-Student Oral/Poster Presenter Registration||450 €||500 €|
|Student Oral/Poster Presenter Registration||350 €||400 €|
|Listener Registration||250 €||300 €|
|Local participation||login to see||login to see|
|Additional Paper Publication||100 €|
|Extra Proceedings Book||50 €|
Selected Conference Papers
1)21st Century Biotechnological Research and Development Advancements for Industrial Development in India
2)Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance
Atul Khurana, Rajul Rastogi, Hans-Joachim Gamperl
The pharmaceutical companies are getting more inclined towards patient support programs (PSPs) which assist patients and/or healthcare professionals (HCPs) in more desirable disease management and cost-effective treatment. The utmost objective of these programs is patient care. The PSPs may include financial assistance to patients, medicine compliance programs, access to HCPs via phone or online chat centers, etc. The PSP has a crucial role in terms of customer acquisition and retention strategies. During the conduct of these programs, Marketing Authorisation Holder (MAH) may receive information related to concerned medicinal products, which is usually reported by patients or involved HCPs. "This information may include suspected adverse reaction(s) during/after administration of medicinal products."
Hence, the MAH should design PSP to comply with regulatory reporting requirements and avoid non-compliance during PV inspection. The emergence of wireless health devices is lowering the burden on patients to manually incorporate safety data, and building a significant option for patients to observe major swings in reference to drug safety. Therefore, to enhance the adoption of these programs, MAH not only needs to aware patients about advantages of the program, but also recognizes the importance of time of patients and commitments made in a constructive manner. It is indispensable that strengthening the public health is considered as the topmost priority in such programs, and the MAH is compliant to Pharmacovigilance (PV) requirements along with regulatory obligations.
3)Management Software for the Elaboration of an Electronic File in the Pharmaceutical Industry Following Mexican Regulations
M. Peña Aguilar Juan, Ríos Hernández Ezequiel, R. Valencia Luis
4)Polydopamine Nanoparticle as a Stable and Capacious Nano-Reservoir of Rifampicin
Tasnuva Tamanna, Aimin Yu
5)Determinants of Profitability in Indian Pharmaceutical Firms in the New Intellectual Property Rights Regime
Shilpi Tyagi, D. K. Nauriyal
6)Quality Based Approach for Efficient Biologics Manufacturing
Takashi Kaminagayoshi, Shigeyuki Haruyama
7)Controlled Release of Glucosamine from Pluronic-Based Hydrogels for the Treatment of Osteoarthritis
Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
8)Use of Curcumin in Radiochemotherapy Induced Oral Mucositis Patients: A Control Trial Study
9)Learners’ Violent Behaviour and Drug Abuse as Major Causes of Tobephobia in Schools
10)The Effect of a Three-Month Training Program on the Back Kyphosis of Former Male Addicts
M. J. Pourvaghar, Sh. Khoshemehry
11)Speciation, Preconcentration, and Determination of Iron(II) and (III) Using 1,10-Phenanthroline Immobilized on Alumina-Coated Magnetite Nanoparticles as a Solid Phase Extraction Sorbent in Pharmaceutical Products
Hossein Tavallali, Mohammad Ali Karimi, Gohar Deilamy-Rad
12)Treatment of Mycotic Dermatitis in Domestic Animals with Poly Herbal Drug
U. Umadevi, T. Umakanthan
13)Radiochemical Purity of 68Ga-BCA-Peptides: Separation of All 68Ga Species with a Single iTLC Strip
Anton A. Larenkov, Alesya Ya Maruk
14)Identifying a Drug Addict Person Using Artificial Neural Networks
Mustafa Al Sukar, Azzam Sleit, Abdullatif Abu-Dalhoum, Bassam Al-Kasasbeh
15)Co-payment Strategies for Chronic Medications: A Qualitative and Comparative Analysis at European Level
Pedro M. Abreu, Bruno R. Mendes